Conversion Disorder
Conversion disorder is a mental condition in which a person has blindness, paralysis, or other nervous system (neurologic) symptoms that cannot be explained by medical evaluation.
Cluster Number:
Wiki Number: W049
Diagnosis: Conversion Disorder
US Patients: 0.11-0.5%
World Patients:
Sex Ratio: 1M;4W
Age Onset: Ages-10-35
Brain Area: large epinephrine release
Symptoms: psychologically triggered neurological symptoms, numbness, blindness, paralysis or fits,etc.
Progression: Trauma suddenly converted by the brain into physical limitations.
Causes: serious difficulties when no physical basis can be found; usually in motor or sensory systems
Medications:
Therapies: hypnosis, psychotherapy, physical therapy, stress management, transcranial magnetic stimulation; depression may occur.
Youtube Video: A patient’s journey of recovery from
Functional Neurological Disorder at Mass General Hospital
Amazon or Library Book: Out Of My Mind (Conversion Disorder)
Click the book to link or order from Amazon.
Support Group: facebook.com/groups/859712170775277 (Conversion Disorder Group)
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.07.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Harmonizing two measures of adaptive functioning using computational approaches: prediction of vineland adaptive behavior scales II (VABS-II) from the adaptive behavior assessment system II (ABAS-II) scoresby Corinna Smith on December 4, 2024
CONCLUSION: Overall, our results supported the feasibility of harmonization. Our results suggest that a linear regression model trained on the ABAS composite score, the ABAS raw domain scores, and age, sex, and diagnosis would provide an acceptable trade-off between accuracy, parsimony, and data collection and processing complexity.
- Glutamic acid decarboxylase antibody-spectrum disorders and type 1 diabetes mellitus in a patient following allogenic hematopoietic cell transplantation with review of literatureby Shinichiro Sano on December 4, 2024
Glutamic acid decarboxylase (GAD) is an enzyme that catalyzes the conversion of glutamic acid into γ-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system (CNS). GAD is widely expressed in the CNS and pancreatic β-cells. GABA produced by GAD plays a role in regulating insulin secretion in pancreatic islets. Anti-GAD antibody is an established marker of type 1 diabetes mellitus (T1DM) and is also associated with stiff-person syndrome (SPS) and several...
- Hysterical motility disorders during the First World War: cases from the orthopaedic department of the Red Cross Hospital in Zagrebby Stella Fatović-Ferenčić on December 2, 2024
CONCLUSION: We have demonstrated that a significant number of patients with motility disorders of psychogenic origin were treated at the orthopaedic department of the Red Cross Hospital in Zagreb. The detailed descriptions left by our predecessors can be used to trace the epidemiology and evolution of these disorders over time, including complex conditions like conversion disorder.
- Mechanism of Bacillus cooperating with silicon to re-balance chlorophyll metabolism and restore carbon metabolism of Glycyrrhiza uralensis Fisch. Seedlings exposed to salt-drought stressby Xueying Peng on December 1, 2024
Salt-drought is a major environmental event affecting crop productivity and quality by causing chlorophyll (Chl) and carbon balance disorder. There has been growing interest in the application of endophyte and silicon (Si), as inoculants for saline and drought land restoration. This study investigates the impact of Bacillus (Bs), Si, and Bs + Si on the disorder of Chl metabolism and carbon balance of G. uralensis seedlings under salt-drought stress (SD). Results showed that both Bs and Si...